News
BioMed Alliance calls for a strong and ambitious Critical Medicines Act
As the trilogue negotiations on the Critical Medicines Act (CMA) continue, the BioMed Alliance has published a statement outlining the concerns and recommendations of healthcare professionals across E...
Healthcare professionals share their views on the future of the regulatory system for medical devices and IVDs
With the recent publication of the European Commission's proposal to revise the Medical Devices Regulation and In Vitro Diagnostics, the EU has the opportunity to modernise the regulatory framework. B...
How to balance innovation and privacy protection in the healthcare sector: BioMed Alliance recommendations on the Digital Omnibus proposal
As healthcare and research continue to embrace digital transformation, navigating the complex regulatory landscape is more challenging than ever. To address this, BioMed Alliance has released a positi...
Coalition for Reducing Bureaucracy in Clinical Trials publishes new article with recommendations
The Coalition for Reducing Bureaucracy in Clinical Trials (RBinCT), which includes a broad range of medical societies, patient organisations, and BioMed Alliance has published a new article online in...
BioMed Alliance and 19 other civil society organisations call for strong health funding under the next EU Multiannual Financial Framework
On 6 November 2025, the BioMed Alliance, together with 19 other civil society organisations representing patients, European Reference Networks (ERNs), healthcare professionals, and the wider health co...
Medical community proposes new recommendations to simplify the regulatory framework for digital health
On 14 October 2025, BioMed Alliance published a new document highlighting the recommendations of healthcare professionals and researchers on the digitalisation of healthcare and the simplification of...
BeWell Project launches public consultation on the future of Europe’s health and care workforce
The BeWell Project, in which BioMed Alliance is a partner, has launched a public consultation to gather input on its European Skills Strategy for the health and care workforce. The aim is to shape a s...
Biomed Alliance response to the Call for Evidence on Medical devices and In Vitro Diagnostics – targeted revision of EU rules
On 6 October 2025, the BioMed Alliance submitted its response to the European Commission’s call for evidence regarding the targeted revision of the Medical Devices Regulation (MDR) and the In Vitro...
Clinical research in Europe: Putting quality and patient safety first. Reducing Bureaucracy in Clinical Trials publishes new recommendations
The Coalition for Reducing Bureaucracy in Clinical Trials, which includes a broad range of medical societies and patient organisations, has published an updated set of recommendations which aim to red...
New CORE-MD recommendations on strengthening clinical evidence for high-risk medical devices
On 15 September 2025, the CORE-MD (Coordinating Research and Evidence for high-risk Medical Devices) consortium published new expert recommendations in The Lancet Regional Health Europe on how to impr...
BioMed Alliance responds to European Commission’s call for evidence on ERA Act
On September 10 2025, the BioMed Alliance submitted its response to the European Commission’s call for evidence for an impact assessment on the upcoming European Research Era (ERA) Act. While welcom...
Users of medical devices call for urgent reform to EU Medical Devices Regulation (MDR)
Today, the BioMed Alliance, together with the European Patients Forum (EPF), the European Association of Hospital Pharmacists (EAHP), and the European Hospital and Healthcare Federation (HOPE), publis...